ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
|
Manuscript Source |
Invited Manuscript |
All Author List |
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, Shuuhei Yamamoto, Takashi Matsuii, Yoshinori Saigusa, Yoshinori Igarashi and Iruru Maetani |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Manabu Watanabe, MD, PhD, Professor, Division of Gastroenterology and Hepatology, Department of Internal medicine, Toho University Medical Center, Ohashi Hosipital, 2-17-6, Ohashi, Meguro-ku, Tokyo 153-8515, Japan. manabu62@med.toho-u.ac.jp |
Key Words |
Hepatocellular carcinoma; Contrast-enhanced ultrasonography; Transarterial chemoembolization; Drug-eluting beads; Intra-arterial contrast-enhanced ultrasonography |
Core Tip |
To assess the usefulness of intra-arterial contrast-enhanced ultrasonography (IAUS) during transarterial chemoembolization (TACE) with drug-eluting beads (DEB) for 39 hepatocellular carcinoma (HCC). Complete and incomplete treatments were 26 and 13, respectively. One month after treatment, 25 and 1 lesions were judged to be CR and PR, respectively, and at 6 mo after treatment, the results were CR, PR, SD and PD for 24, 1, 0 and 1 of these lesions, respectively, in the 26 completely treated lesions. The overall CR rate at 6 mo after treatment was 61.5% (24/39). A combination of DEB-TACE with IAUS can improve the therapeutic effects in HCC patients. |
Publish Date |
2018-01-26 08:09 |
Citation |
Shiozawa K, Watanabe M, Ikehara T, Yamamoto S, Matsui T, Saigusa Y, Igarashi Y, Maetani I. Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. World J Hepatol 2018; 10(1): 95-104 |
URL |
http://www.wjgnet.com/1948-5182/full/v10/i1/95.htm |
DOI |
http://dx.doi.org/10.4254/wjh.v10.i1.95 |